Sign in

CIK 0001611747 · Non-accelerated filer

Scinai Immunotherapeutics Ltd.

Sign in to watch
Ticker
SCNI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972-8-9302529
Business address
JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, Israel, 00000
Former names
BiondVax Pharmaceuticals Ltd.
  1. POS AM Other Post-effective Amendment for Registration Statement
  2. 6-K Event Report of Foreign Issuer
  3. 6-K Event Report of Foreign Issuer
  4. 424B3 Offering Prospectus
  5. 6-K Event Report of Foreign Issuer
  6. 6-K Event Report of Foreign Issuer
  7. EFFECT Other Notice of Effectiveness
  8. POS AM Other Post-effective Amendment for Registration Statement
  9. 20-F Report Annual and Transition Report of Foreign Private Issuers
  10. NT 20-F Other Notification of Inability to Timely File
  11. 6-K Event Report of Foreign Issuer
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. 6-K Event Report of Foreign Issuer
  14. 424B3 Offering Prospectus
  15. EFFECT Other Notice of Effectiveness
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. F-1/A Offering Registration Statement for Certain Foreign Private Issuers
  18. UPLOAD Other SEC-generated Letter
  19. 6-K Event Report of Foreign Issuer
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 4 of 25 · 498 filings